Views
11 months ago

2014 Winter Highlights of Hope

  • Text
  • Andel
  • Institute
  • Rapids
  • Sponsors
  • Scientific
  • Epigenetics
  • Michigan
  • Jovinge
  • Cardiovascular
  • Neurodegenerative
  • Vai.org

Established by Jay and

Established by Jay and Betty Van Andel in 1996, Van Andel Institute (VAI) is an independent research and educational organization based in Grand Rapids, Michigan. Through biomedical research and science education Van Andel Institute is committed to improving the health and enhancing the lives of current and future generations. Winter 2014 Van Andel Institute’s Highlights of Hope Table of contents Van Andel Research Institute (VARI) VAI’s research arm is dedicated to studying the genetic, cellular and molecular origins of cancer, Parkinson’s and other diseases and working to translate those findings into effective therapies. Van Andel Education Institute (VAEI) VAI’s education arm is dedicated to strengthening science education and preparing and motivating individuals to pursue science-related professions through the educational spectrum. Purple Community—100% Hope® is Van Andel Institute’s grassroots initiative to empower supporters in businesses, communities, schools and other organizations to increase awareness, celebrate survivors, honor loved ones and raise funds. Van Andel Institute Giving Join our fight! Learn how you can support Van Andel Institute by contacting the Development Department at development@vai.org or 616.234.5120. On the Cover Dr. Peter A. Jones was appointed Van Andel Institute’s Director of Research and Chief Scientific Officer in December 2013. Dr. Jones joins VAI from the University of Southern California. Read the complete story on pages 4-7. 3 A Letter from David Van Andel 4 Van Andel Institute is Proud to Introduce Dr. Peter A. Jones, Director of Research and Chief Scientific Officer 8 Cutting-Edge Cardiovascular Research Comes to Grand Rapids 10 Recent Discovery Identifies Novel Cancer Treatment Strategy 11 New Hires Broaden Van Andel Institute’s Center Dr. George Vande Woude Receives Prestigious Award in Biological Science 12 Van Andel Institute Graduate School Receives Accreditation 14 Fourth Student Graduates from Van Andel Institute Graduate School 15 Science Conference Draws Record Crowd 16 Students Exceed Five-Year, 0,000 Fundraising Goal 18 Fighting Cancer with Hockey 20 Couture for a Cure Event Photos 21 Hope on the Hill Event Photos 22 Van Andel Institute Breast Cancer Luncheon Event Photos Van Andel Institute National Initiative New York Event Photos 23 Around the World Event Photos 25 Smart Cancer Research: Van Andel Institute Receives National Media Attention 26 Going to Bat for Breast Cancer 27 A Legacy of Caring Board of Governors & J-Board Members 28 Upcoming Events

A Letter from David Van Andel Chairman & CEO, Van Andel Institute A new year is filled with excitement, hope and the promise of new beginnings. We set resolutions and goals, begin new routines and seek to improve upon the previous year. I have never been more enthusiastic for a new year thanks to the great strides in biomedical research and science education happening at Van Andel Institute. The efforts of the passionate individuals at Van Andel Institute provide hope for a new year; hope to students for an exciting future in the sciences; and hope to patients and their loved ones that improved treatments are possible. We are excited for the direction Dr. Peter Jones brings to Van Andel Institute as the new Director of Research and Chief Scientific Officer. His work in epigenetics is a valuable addition to the Institute and opens doors for new discoveries. We also welcome Dr. Stefan Jovinge and our continued partnership with Spectrum Health. The addition of Dr. Jones, Dr. Jovinge and others to Van Andel Research Institute’s staff helps us expand our ability to research disease from different approaches and disciplines. Van Andel Institute researchers made key discoveries in cancer and neurodegenerative diseases in 2013. A novel cancer treatment strategy that can slow tumor growth while protecting normal tissue was recently featured on the cover of Cancer Research, and advances took place in the fight against pancreatic and lung cancer, glioblastoma and lymphoma, to name a few. Researchers are also developing a new “anti-diabetic drug” that may be able to slow disease progression and prevent movement disorders in Parkinson’s disease patients. The scientists of the future are receiving an innovative education at Van Andel Education Institute. This past year, Van Andel Institute Graduate School received accreditation from the Higher Learning Council for its unique Ph.D. program and celebrated the commencement of its latest graduate. Van Andel Education Institute’s inquiry-based curriculum was integrated in 17 school districts and continues to be a model for education reform. The efforts of the passionate individuals at Van Andel Institute provide hope for a new year; hope to students for an exciting future in the sciences; and hope to patients and their loved ones that improved treatments are possible. Your support enables us to continue our work and encourages us every day. Thank you for your continued partnership in our mission. Warm regards, David Van Andel Chairman & CEO 03

Publications by Year